MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
442.19%
Quick Ratio
262.38%
Cash Ratio
113.57%
Debt to Asset Ratio
52.08%
Unit: Thousand (K) dollars
Assets Breakdown
    • Inventory
    • Cash and cash equivalents
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Lease liabilities, net of curren...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
571,148
464,450
801,282
613,077
Short-term investments
217,341
188,739
138,368
237,916
Accounts receivable, net
376,824
394,817
398,233
395,739
Inventory
904,273
1,001,112
914,744
1,077,166
Manufacturing-related deposits and prepaids
48,454
72,785
113,455
206,062
Other current assets
105,784
187,973
171,856
192,349
Total current assets
2,223,824
2,309,876
2,537,938
2,722,309
Property and equipment, gross
-
-
626,040
-
Less accumulated depreciation
-
-
280,472
-
Less accumulated impairment loss
-
-
443
-
Property and equipment, net
325,991
336,241
345,125
358,936
Right of use assets
120,847
124,059
125,495
139,167
Non-current inventory
226,333
174,865
184,543
198,601
Non-current investments
145,372
81,936
1,048
1,040
Other non-current assets
146,145
151,957
155,554
73,384
Total assets
3,188,512
3,178,934
3,349,703
3,493,437
Accounts payable
50,982
70,376
280,841
94,015
Accrued expenses
325,232
302,372
359,659
295,793
Deferred revenue, current portion
110,132
116,037
443,397
485,449
Contingent consideration, current portion
-
-
-
36,000
Other current liabilities
16,562
10,379
11,393
10,168
Total current liabilities
502,908
499,164
1,095,290
921,425
Long-term debt
847,623
838,162
828,974
1,035,146
Lease liabilities, net of current portion
198,226
198,505
199,378
215,042
Deferred revenue, net of current portion
110,132
136,354
83,910
0
Contingent consideration
-
-
0
300
Other non-current liabilities
1,825
1,647
1,529
1,404
Total liabilities
1,660,714
1,673,832
2,209,081
2,173,317
Common stock, 0.0001 par value, 198,000,000 shares authorized 106,279,142 and 105,623,500 issued and outstanding, respectively, at june 30, 2026 and 105,615,096 and 104,964,220 issued and outstanding, respectively, at december 31, 2025
11
11
11
11
Treasury stock, at cost, 655,642 and 650,876 shares at march 31, 2026 and december 31, 2025, respectively
25,263
25,263
25,263
25,263
Additional paid-in capital
6,104,530
6,076,500
6,042,586
5,986,689
Accumulated other comprehensive income (loss), net of tax
-565
-121
272
220
Accumulated deficit
-4,550,915
-4,546,025
-4,876,984
-4,641,537
Total stockholders equity
1,527,798
1,505,102
1,140,622
1,320,120
Total liabilities and stockholders equity
3,188,512
3,178,934
3,349,703
3,493,437
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Inventory$904,273K (-9.03%↓ Y/Y)Cash and cashequivalents$571,148K (11.86%↑ Y/Y)Accounts receivable, net$376,824K (-28.54%↓ Y/Y)Short-term investments$217,341K (-24.94%↓ Y/Y)Other current assets$105,784K (-17.09%↓ Y/Y)Manufacturing-related deposits andprepaids$48,454K (-76.70%↓ Y/Y)Total current assets$2,223,824K (-16.30%↓ Y/Y)Property and equipment,net$325,991K (-12.33%↓ Y/Y)Non-current inventory$226,333K (16.27%↑ Y/Y)Other non-currentassets$146,145K (75.79%↑ Y/Y)Non-current investments$145,372K (320.10%↑ Y/Y)Right of use assets$120,847K (-15.52%↓ Y/Y)Total assets$3,188,512K (-13.35%↓ Y/Y)Total liabilities andstockholders equity$3,188,512K (-13.35%↓ Y/Y)Total liabilities$1,660,714K (-28.49%↓ Y/Y)Total stockholdersequity$1,527,798K (12.55%↑ Y/Y)Accumulated deficit-$4,550,915K (-2.00%↓ Y/Y)Treasury stock, at cost,655,642 and 650,876...$25,263K (0.00%↑ Y/Y)Accumulated othercomprehensive income (loss),...-$565K (-1007.84%↓ Y/Y)Long-term debt$847,623K (-25.61%↓ Y/Y)Total currentliabilities$502,908K (-45.33%↓ Y/Y)Lease liabilities,net of current...$198,226K (-7.55%↓ Y/Y)Deferred revenue, net ofcurrent portion$110,132K Other non-currentliabilities$1,825K (51.58%↑ Y/Y)Additional paid-in capital$6,104,530K (4.45%↑ Y/Y)Common stock, 0.0001par value,...$11K (10.00%↑ Y/Y)Accrued expenses$325,232K (-13.82%↓ Y/Y)Deferred revenue,current portion$110,132K (-72.15%↓ Y/Y)Accounts payable$50,982K (-62.71%↓ Y/Y)Other currentliabilities$16,562K (59.01%↑ Y/Y)
logo (1) copy-svg

Sarepta Therapeutics, Inc. (SRPT)

logo (1) copy-svg

Sarepta Therapeutics, Inc. (SRPT)